MabSwitch actively invites pharmaceutical companies, clinics, manufacturing CROs and suppliers of affinity chromatography materials to discuss the opportunities of affinity switches for their antibody based immunotherapies and products.

MabSwitch is open for partnering, co-development or licensing.